27
|
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71:877-92. [PMID: 12145742 PMCID: PMC378543 DOI: 10.1086/342734] [Citation(s) in RCA: 1304] [Impact Index Per Article: 59.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2002] [Accepted: 07/09/2002] [Indexed: 01/08/2023] Open
Abstract
The cause of schizophrenia is unknown, but it has a significant genetic component. Pharmacologic studies, studies of gene expression in man, and studies of mouse mutants suggest involvement of glutamate and dopamine neurotransmitter systems. However, so far, strong association has not been found between schizophrenia and variants of the genes encoding components of these systems. Here, we report the results of a genomewide scan of schizophrenia families in Iceland; these results support previous work, done in five populations, showing that schizophrenia maps to chromosome 8p. Extensive fine-mapping of the 8p locus and haplotype-association analysis, supplemented by a transmission/disequilibrium test, identifies neuregulin 1 (NRG1) as a candidate gene for schizophrenia. NRG1 is expressed at central nervous system synapses and has a clear role in the expression and activation of neurotransmitter receptors, including glutamate receptors. Mutant mice heterozygous for either NRG1 or its receptor, ErbB4, show a behavioral phenotype that overlaps with mouse models for schizophrenia. Furthermore, NRG1 hypomorphs have fewer functional NMDA receptors than wild-type mice. We also demonstrate that the behavioral phenotypes of the NRG1 hypomorphs are partially reversible with clozapine, an atypical antipsychotic drug used to treat schizophrenia.
Collapse
Affiliation(s)
- Hreinn Stefansson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Engilbert Sigurdsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Valgerdur Steinthorsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Soley Bjornsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Thordur Sigmundsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Shyamali Ghosh
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Jon Brynjolfsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Steinunn Gunnarsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Omar Ivarsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Thomas T. Chou
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Omar Hjaltason
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Birgitta Birgisdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Helgi Jonsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Vala G. Gudnadottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Elsa Gudmundsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Asgeir Bjornsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Brynjolfur Ingvarsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Andres Ingason
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Sigmundur Sigfusson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Hronn Hardardottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Richard P. Harvey
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Donna Lai
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Mingdong Zhou
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Daniela Brunner
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Vincent Mutel
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Acuna Gonzalo
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Greg Lemke
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Jesus Sainz
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Gardar Johannesson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Thorkell Andresson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Daniel Gudbjartsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Andrei Manolescu
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Michael L. Frigge
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Mark E. Gurney
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Augustine Kong
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Jeffrey R. Gulcher
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Hannes Petursson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Kari Stefansson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| |
Collapse
|